Multivariate analysis of factors affecting OS, DFS, and RFS
. | No. . | Relative risk . | 95% CI . | P . |
|---|---|---|---|---|
| DFS | ||||
| Acute GVHD | ||||
| None | 79 | 1.0 | NA | NA |
| Grades 1-2 | 58 | 0.66 | 0.37-1.2 | .165 |
| Grades 3-4 | 13 | 2.73 | 1.3-5.6 | .007 |
| Timing | ||||
| Intensive | 94 | 1.0 | NA | NA |
| Standard | 52 | 1.8 | 1.1-3.0 | .027 |
| Hepatomegaly | ||||
| No | 95 | 1.0 | NA | NA |
| Yes | 55 | 2.0 | 1.2-3.3 | .009 |
| RFS | ||||
| Acute GVHD | ||||
| None | 79 | 1.0 | NA | NA |
| Grades 1-2 | 58 | 0.36 | 0.17-0.76 | .008 |
| Grades 3-4 | 13 | 0 | NA | NA |
| Hepatomegaly | ||||
| No | 95 | 1.0 | NA | NA |
| Yes | 55 | 2.2 | 1.2-4.2 | .014 |
| OS | ||||
| Acute GVHD | ||||
| None | 79 | 1.0 | NA | NA |
| Grades 1-2 | 58 | 1.0 | 0.53-2.0 | .918 |
| Grades 3-4 | 13 | 4.5 | 2.1-9.7 | < .001 |
| Timing | ||||
| Intensive | 94 | 1.0 | NA | NA |
| Standard | 52 | 1.9 | 1.0-3.4 | .041 |
. | No. . | Relative risk . | 95% CI . | P . |
|---|---|---|---|---|
| DFS | ||||
| Acute GVHD | ||||
| None | 79 | 1.0 | NA | NA |
| Grades 1-2 | 58 | 0.66 | 0.37-1.2 | .165 |
| Grades 3-4 | 13 | 2.73 | 1.3-5.6 | .007 |
| Timing | ||||
| Intensive | 94 | 1.0 | NA | NA |
| Standard | 52 | 1.8 | 1.1-3.0 | .027 |
| Hepatomegaly | ||||
| No | 95 | 1.0 | NA | NA |
| Yes | 55 | 2.0 | 1.2-3.3 | .009 |
| RFS | ||||
| Acute GVHD | ||||
| None | 79 | 1.0 | NA | NA |
| Grades 1-2 | 58 | 0.36 | 0.17-0.76 | .008 |
| Grades 3-4 | 13 | 0 | NA | NA |
| Hepatomegaly | ||||
| No | 95 | 1.0 | NA | NA |
| Yes | 55 | 2.2 | 1.2-4.2 | .014 |
| OS | ||||
| Acute GVHD | ||||
| None | 79 | 1.0 | NA | NA |
| Grades 1-2 | 58 | 1.0 | 0.53-2.0 | .918 |
| Grades 3-4 | 13 | 4.5 | 2.1-9.7 | < .001 |
| Timing | ||||
| Intensive | 94 | 1.0 | NA | NA |
| Standard | 52 | 1.9 | 1.0-3.4 | .041 |
NA indicates not applicable.